COPD
The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.
Type 2 Inflammation: A Common Theme Among Several Chronic Diseases
Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.
Exploring the Differential Effectiveness of ICS by Smoking Status in COPD
Tailoring COPD Treatments Among Smokers, Nonsmokers
Dupilumab Improves Lung Function, Type 2 Inflammation in COPD
Dr Surya Bhatt on Dupilumab's Promise in Reducing COPD Exacerbations, Enhancing Quality of Life
Dr Surya Bhatt Highlights NOTUS Trial Findings, Promising Dupilumab Results
Dr Surya Bhatt Discusses the Role of Dupilumab in Type 2 Inflammation, Exacerbations in COPD
Dr Debra Boyer: Childhood Respiratory Illness Impacts Adult Health
Key Takeaways and Considerations Surrounding COPD Therapies
Cost Drivers Impacting Treatment Strategies for COPD
Role of Non-Medication Strategies in COPD Treatment Pathway
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage
Reflecting on the Real-World Use of Biologic Therapy in Asthma Management
Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies
Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists
More News
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
